China Animal Healthcare said talks to arrange third-party financing for the possible delisting of its shares from the SGX are now at an “advanced stage”.
On May 22, the manufacturer of animals drugs announced that it would pay 30 cents per share to investors if the delisting proceeds as plan.
It had said it intends to maintain its primary listing in Hong Kong. Shareholders who do not accept the exit offer would have their shares transferred to Hong Kong.
No comments:
Post a Comment